Amgen expands pact with Amazon to usher drug manufacturing into the AI era

Seeking to identify ways to improve the discovery and production of medicines, Amgen is expanding its partnership with tech giant Amazon.

Specifically, Amgen is growing its decade-old collaboration with Amazon Web Services (AWS)—a widely used cloud platform—to create generative AI in a bid to increase the manufacturing throughput of pharmaceuticals.